Trials / Completed
CompletedNCT00924742
A Single-Dose Pharmacokinetics Study of Tapimycin Injection
A Single-Dose Pharmacokinetics Study of Tapimycin Injection(Piperacillin 4 g + Tazobactam 0.5 g Powder for Injection) Administered Under Fasting Conditions to Healthy Adult Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Tri-Service General Hospital · Academic / Other
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the pharmacokinetic properties of Tapimycin injection (piperacillin 4 g + tazobactam 0.5 g powder for injection) in healthy volunteers under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tapimycin (piperacillin 4 g + tazobactam 0.5g) | One intravenous infusion (piperacillin 4 g + tazobactam 0.5 g powder for injection) over 30 minutes/single dosing |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2009-06-19
- Last updated
- 2009-06-19
Source: ClinicalTrials.gov record NCT00924742. Inclusion in this directory is not an endorsement.